2024.5.20
Prior immune checkpoint inhibitors may enhance severe hypersensitivity related to selpercatinib in RET fusion gene-positive lung cancer.
著者
Hashimoto K, Kaira K, Imai H, Shiono A, Kagamu H.
J Chemother. 2024 May 20:1-3. doi: 10.1080/1120009X.2024.2352985. Online ahead of print.
PMID: 38766697
